Skip to main content
PRO MEDICUS LIMITED logo

PRO MEDICUS LIMITED — Investor Relations & Filings

Ticker · PME ISIN · AU000000PME8 LEI · 98450085A903D1BMFF27 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2025-01-15 Capital/Financing Update
Country AU Australia
Listing ASX PME

About PRO MEDICUS LIMITED

https://www.promed.com.au

Pro Medicus Limited provides advanced healthcare imaging software and enterprise-wide IT solutions. The company’s core offering is the Visage 7 platform, which employs server-side rendering technology to enable rapid, high-resolution streaming of medical images, including MRI, CT, and X-ray data. Its product suite encompasses diagnostic viewing, vendor-neutral archiving, and clinical workflow management. Designed for large-scale health systems and academic medical centers, the technology supports cloud-based deployments and integrates artificial intelligence to streamline diagnostic processes. The platform focuses on performance and scalability, allowing clinicians to access and interpret complex imaging datasets from multiple locations without the need for local data transfer.

Recent filings

Filing Released Lang Actions
PME signs A$33M, 9-year contract with University of Kentucky 3 pages 188.1KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement about Pro Medicus Limited signing a $33M, 9-year contract with the University of Kentucky. It details the contract terms, the products involved, and the strategic significance of the deal. There are no financial statements, no regulatory certifications, no voting results, or management changes. The document is an update on a capital contract and business development, not a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under Capital/Financing Update (CAP) as it announces a significant contract and revenue stream for the company.
2025-01-15 English
PME signs A$15M, 5-year Visage Archive deal with Duke Heath 2 pages 181.9KB
Regulatory Filings Classification · 95% confidence The document is a company announcement about a new contract deal signed by Pro Medicus Limited with Duke University Health System. It details the contract value, duration, and product implementation but does not contain financial statements, regulatory filings, or detailed financial results. The document is relatively short (3346 characters) and serves as a press release or announcement of a business development rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Earnings Release, or Capital Update. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-12-29 English
PME signs A$30M, 7-year contract with Duly Health and Care 2 pages 184.6KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement about Pro Medicus Limited signing a $30 million, 7-year contract with Duly Health and Care. It details the contract terms, the products involved, and includes quotes from the CEO. There is no financial report, earnings data, or regulatory filing referenced. The document is an update on a capital contract deal, specifically a significant financing or business development update. It is not an annual or interim report, audit, or earnings release. It fits best under Capital/Financing Update (CAP) as it announces a major contract and business development with financial implications.
2024-12-22 English
Sale of 1M shares each by founders 2 pages 177.9KB
Director's Dealing Classification · 100% confidence The document is a company announcement dated December 4, 2024, reporting that two co-founders have sold shares representing less than 4% of their holdings. It details the transaction specifics, shareholdings before and after the sale, and includes statements from the Chairman. There is no financial report, earnings data, or regulatory filing referenced. The content focuses on insider share transactions by company directors/executives. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is under 5,000 characters and is a direct announcement of share sales by directors, not a broader financial or regulatory report.
2024-12-03 English
Change of Director's Interest Notice - Anthony Hall 3 pages 446.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references Listing Rule 3.19A.2, which pertains to disclosures of changes in directors' interests in securities. The content details the director's name, date of last notice, nature of securities held, number of shares before and after the change, and the nature of the transaction (on-market trade). It is a formal notification of a director's personal share transactions. There is no financial performance data, no management discussion, no earnings information, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is about 4500 characters, which is consistent with a detailed insider trading notice. Therefore, the correct classification is DIRS (Director's Dealing).
2024-12-03 English
Change of Director's Interest Notice - Sam Hupert 3 pages 444.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references Listing Rule 3.19A.2, which pertains to disclosures of changes in directors' interests in securities. The content details a director's shareholding changes, including the number of shares disposed and held before and after the change, the nature of the transaction (on-market trade), and the value per share. There is no financial performance data, earnings information, or report publication mentioned. The document is a regulatory disclosure of insider trading by a director, which fits the definition of Director's Dealing filings. The document length is 4184 characters, consistent with a detailed insider transaction notice rather than a full report or announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2024-12-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.